Investigation in the cannabigerol derivative VCE-003.2 as a disease-modifying agent in a mouse model of experimental synucleinopathy.

Behav Brain Funct · 2024 · PMC11531178 · PMID 39487447

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a numerical trendno p-value reported

4 ) and a numerical trend in GFAP immunostaining (Fig. 4 and representative images in Supplementary File 8 ).

also in 426 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.